|
⚲
|
| Keyboard |
| MPM Oncology Impact Management LP
✚
|
|
|---|---|
| CRD # | 281892 |
| SEC # | 801-106988 |
| CIK # | 0001687078 |
| AUM | |
| Employees | 7 (71% Investors, 0% Brokers) |
| Phone | 617-425-9200 |
| Address | 168 Woodland Road Chestnut Hill, MA 02467 |
| Source | [IAPD] [EDGAR] [Website] [Twitter] [LinkedIn] |
| Total AUM ($M) |
|---|
| CIK | Period |
|---|---|
| 0001687078 |
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| DBV Technologies Sa | 108.9 | ||
| Cullinan Oncology Inc | 108.7 | ||
| Liquidia Corp | 53.0 | ||
| Alumis Inc | 52.6 | ||
| Edgewise Therapeutics Inc | 52.3 | ||
| Revolution Medicines Inc | 49.3 | ||
| Agios Pharmaceuticals Inc | 44.2 | ||
| Corcept Therapeutics Inc | 39.7 | ||
| Trevi Therapeutics Inc | 39.4 | ||
| Magenta Therapeutics Inc | 35.6 | ||
| Xenon Pharmaceuticals Inc | 34.2 | ||
| Helix Acquisition Corp | 33.8 | ||
| Desert Gateway Inc | 33.7 | ||
| Evommune Inc | 33.5 | ||
| Cytokinetics Inc | 33.0 | ||
| Syndax Pharmaceuticals Inc | 31.3 | ||
| Context Therapeutics Inc | 28.0 | ||
| Tocagen Inc | 25.9 | ||
| Marika Inc | 25.7 | ||
| Dyne Therapeutics Inc | 25.5 | ||
| Stoke Therapeutics Inc | 25.0 | ||
| Corvus Pharmaceuticals Inc | 24.5 | ||
| Relay Therapeutics Inc | 23.5 | ||
| Tarsus Pharmaceuticals Inc | 23.1 | ||
| Oric Pharmaceuticals Inc | 22.9 | ||
| Uniqure NV | 22.4 | ||
| Monte Rosa Therapeutics Inc | 19.4 | ||
| Natera Inc | 18.6 | ||
| Eliem Therapeutics Inc | 17.8 | ||
| Prev | Page 1 | Next | |||
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 3 | 1,189.3 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 3 | 1,189.3 |
| By Discretionary | ||
| Discretionary | 3 | 1,189.3 |
| Non-Discretionary | 0 | 0.0 |
| Total | 3 | 1,189.3 |
| By Non-United States Persons | ||
| Non-United States Persons | 1,189.3 | |
| United States Persons | 0.0 | |
| Total | 3 | 1,189.3 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001687078] | |
| 3 | [0001687078] | |
| 4 | [0001687078] | |
| SC 13D | [0001687078] | |
| SC 13G | [0001687078] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Werewolf Therapeutics Inc HOWL
Common Stock
|
2025-12-04 | Sell | 83,230 | $0.97 | 80,733 |
|
Werewolf Therapeutics Inc HOWL
Common Stock
|
2025-12-03 | Sell | 57,225 | $0.87 | 49,786 |
|
Werewolf Therapeutics Inc HOWL
Common Stock
|
2025-12-02 | Sell | 59,277 | $0.89 | 52,757 |
|
Werewolf Therapeutics Inc HOWL
Common Stock
|
2025-12-01 | Sell | 60,917 | $0.94 | 57,262 |
|
Werewolf Therapeutics Inc HOWL
Common Stock
|
2025-11-28 | Sell | 20,277 | $0.99 | 20,074 |
|
Werewolf Therapeutics Inc HOWL
Common Stock
|
2025-11-26 | Sell | 60,733 | $0.98 | 59,518 |
|
Werewolf Therapeutics Inc HOWL
Common Stock
|
2025-11-25 | Sell | 42,533 | $0.92 | 39,130 |
|
Werewolf Therapeutics Inc HOWL
Common Stock
|
2025-11-24 | Sell | 88,802 | $0.98 | 87,026 |
|
Werewolf Therapeutics Inc HOWL
Common Stock
|
2025-11-21 | Sell | 64,331 | $0.83 | 53,395 |
|
Werewolf Therapeutics Inc HOWL
Common Stock
|
2025-11-20 | Sell | 41,152 | $0.89 | 36,625 |
|
Werewolf Therapeutics Inc HOWL
Common Stock
|
2025-11-19 | Sell | 66,324 | $0.94 | 62,345 |
|
Werewolf Therapeutics Inc HOWL
Common Stock
|
2025-11-18 | Sell | 52,627 | $0.93 | 48,943 |
|
Werewolf Therapeutics Inc HOWL
Common Stock
|
2025-11-17 | Sell | 57,061 | $0.95 | 54,208 |
|
Werewolf Therapeutics Inc HOWL
Common Stock
|
2025-11-14 | Sell | 61,640 | $0.93 | 57,325 |
|
Werewolf Therapeutics Inc HOWL
Common Stock
|
2025-11-13 | Sell | 90,951 | $0.98 | 89,132 |
|
Werewolf Therapeutics Inc HOWL
Common Stock
|
2025-11-12 | Sell | 40,669 | $1.09 | 44,329 |
|
Werewolf Therapeutics Inc HOWL
Common Stock
|
2025-11-11 | Sell | 55,810 | $1.14 | 63,623 |
|
Werewolf Therapeutics Inc HOWL
Common Stock
|
2025-11-10 | Sell | 48,570 | $1.18 | 57,313 |
|
Werewolf Therapeutics Inc HOWL
Common Stock
|
2025-11-07 | Sell | 68,480 | $1.11 | 76,013 |
|
Werewolf Therapeutics Inc HOWL
Common Stock
|
2025-11-06 | Sell | 54,452 | $1.21 | 65,887 |
| showing 20 of 200 most recent transactions | |||||
| Related Firms | State | AUM |
|---|---|---|
|
MPM Asset Management LLC
✚
|
MA | 3,558.1 M |
|
MPM Oncology Impact Management LP
✚
|
MA |